Page last updated: 2024-10-21

acebutolol and Raynaud Disease

acebutolol has been researched along with Raynaud Disease in 1 studies

Acebutolol: A cardioselective beta-1 adrenergic antagonist with little effect on the bronchial receptors. The drug has stabilizing and quinidine-like effects on cardiac rhythm, as well as weak inherent sympathomimetic action.
acebutolol : An ether that is the 2-acetyl-4-(butanoylamino)phenyl ether of the primary hydroxy group of 3-(propan-2-ylamino)propane-1,2-diol.

Raynaud Disease: An idiopathic vascular disorder characterized by bilateral Raynaud phenomenon, the abrupt onset of digital paleness or CYANOSIS in response to cold exposure or stress.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Holti, G1

Trials

1 trial available for acebutolol and Raynaud Disease

ArticleYear
A comparison of two beta-blocking drugs in patients with Raynaud's phenomenon.
    The Practitioner, 1982, Volume: 226, Issue:1366

    Topics: Acebutolol; Adult; Body Temperature; Clinical Trials as Topic; Double-Blind Method; Female; Humans;

1982